⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIIB News
Biogen Inc. Common Stock
Form 8-K
sec.gov
STOK
BIIB
Stoke Therapeutics Appoints Clare Kahn, Ph.D., to its Board of Directors
businesswire.com
STOK
BIIB
Biocon Announces U.S. Commercial Launch of Bosaya™ and Aukelso™, Denosumab Biosimilars
businesswire.com
BIIB
AMGN
Alloy Therapeutics Enters into Multi-Target Collaboration and License Agreement with Biogen for Use of Alloy’s AntiClastic™ ASO Platform
businesswire.com
BIIB
ALOY
Idiopathic Membranous Nephropathy Market is Predicted to Reach USD 1 Billion by 2036 Due to Rising Therapeutic Options | DelveInsight
globenewswire.com
BIIB
VRTX
AZN
VTRS
NKTR
CLMB
Form 8-K
sec.gov
BIIB
Wearables in Pharma & Biotech Market worth $9.97 billion by 2031 | MarketsandMarkets™
prnewswire.com
BDX
ABT
MASI
AAPL
DXCM
MDT
IRTC
BIIB
GEHC
BSX
VIVK
Systemic Lupus Erythematosus Clinical Trial Pipeline Accelerates as 120+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
globenewswire.com
BIIB
NVS
VTRS
UCB
BMY
ABBV
AZN
CABA
AUR
GSK
VERA
KYMR
NKTR
VRTX
ARWR
Apellis Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Apellis Pharmaceuticals, Inc. - APLS
businesswire.com
APLS
BIIB
Form 8-K
sec.gov
APLS
BIIB